BLOCKSYNTHESE VON OLIGORIBONUKLEOTIDEN

Patent europeic · EP2609107 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2609107
Numer da la dumonda
EP11819230
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
23-08-2011
Publitgà
03-07-2013
Concedì
11-12-2024
La protecziun finescha il pli tard
22-08-2031
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
C07H 21/02 (2006.01)
C07H 21/00 (2006.01)
C07H 23/00 (2006.01)
Prioritad
US 376030 P 23.08.2010
Dumonda PCT
PCT/CA2011/000950 23.08.2011
Publicaziun PCT
WO2012/024776 01.03.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 22-10-2025

    Midada

    Published in Swissreg on 22.10.2025

  3. 01-09-2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  4. 14-01-2025

    Represchentant inscrit

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 14.01.2025

  5. 11-12-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.12.2024

Partidas

Inventur

DAMHA, Masad, J.

St. Hubert Québec J3Y 8N9, CA

HASSLER, Matthew

Saskatoon Saskatchewan S7J 1H2, CA

CHAN, Tak-Hang

Toronto, Ontario M5J 2G2, CA

NANDYALA, Mallikarjuna Reddy

Edmonton, Alberta, T6H 4W9, CA

DONGA, Robert Alexander

Saint-Bruno Québec J3V 5E7, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.